These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15592577)

  • 41. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
    de Lemos JA; Gibson CM; Antman EM; Murphy SA; Morrow DA; Schuhwerk KC; Schweiger M; Coussement P; Van de Werf F; Braunwald E;
    Am Heart J; 2001 Apr; 141(4):592-8. PubMed ID: 11275925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Administration of eptifibatide during transfer for primary PCI in patients with STEMI: effect on Pre-PCI TIMI flow and its correlation with pain-to-therapy time.
    Aquilina M; Varani E; Balducelli M; Vecchi G; Frassineti V; Maresta A
    J Invasive Cardiol; 2009 Mar; 21(3):115-20. PubMed ID: 19258642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
    Ellis SG; Lincoff AM; George BS; Kereiakes DJ; Ohman EM; Krucoff MW; Califf RM; Topol EJ
    Coron Artery Dis; 1994 Jul; 5(7):611-5. PubMed ID: 7952423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
    Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
    Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
    Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longer-term follow-up of patients recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) trial.
    Carver A; Rafelt S; Gershlick AH; Fairbrother KL; Hughes S; Wilcox R;
    J Am Coll Cardiol; 2009 Jul; 54(2):118-26. PubMed ID: 19573727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drip-and-ship for acute ST-segment myocardial infarction: the pharmacoinvasive strategy for patients treated with fibrinolytic therapy.
    Goodman SG; Cantor WJ
    Pol Arch Med Wewn; 2009 Nov; 119(11):726-30. PubMed ID: 19920797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.
    Vlaar PJ; Svilaas T; van der Horst IC; Diercks GF; Fokkema ML; de Smet BJ; van den Heuvel AF; Anthonio RL; Jessurun GA; Tan ES; Suurmeijer AJ; Zijlstra F
    Lancet; 2008 Jun; 371(9628):1915-20. PubMed ID: 18539223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AngioJet Rheolytic thrombectomy during rescue PCI for failed thrombolysis: a single-center experience.
    Sherev DA; Shavelle DM; Abdelkarim M; Shook T; Mayeda GS; Burstein S; Matthews RV
    J Invasive Cardiol; 2006 Jul; 18 Suppl C():12C-16C. PubMed ID: 16883026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction].
    Tsukahara K; Kimura K; Usui T; Okuda J; Kitamura Y; Kosuge M; Sano T; Tohyama S; Nemoto T; Yamanaka O; Yoshii Y; Tochikubo O; Umemura S
    J Cardiol; 2001 Mar; 37(3):143-50. PubMed ID: 11281054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Lewis BS; Murphy SA; McCabe CH; Braunwald E;
    JAMA; 2005 Sep; 294(10):1224-32. PubMed ID: 16143698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
    Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD
    Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction.
    Gershlick AH; Stephens-Lloyd A; Hughes S; Abrams KR; Stevens SE; Uren NG; de Belder A; Davis J; Pitt M; Banning A; Baumbach A; Shiu MF; Schofield P; Dawkins KD; Henderson RA; Oldroyd KG; Wilcox R;
    N Engl J Med; 2005 Dec; 353(26):2758-68. PubMed ID: 16382062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial.
    Zarich SW; Kowalchuk GJ; Weaver WD; Loscalzo J; Sassower M; Manzo K; Byrnes C; Muller JE; Gurewich V
    J Am Coll Cardiol; 1995 Aug; 26(2):374-9. PubMed ID: 7608437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
    Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E;
    Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Management of acute myocardial infarction: What remains of intravenous thrombolysis?].
    Bonnet JL; Bonnet G
    Presse Med; 2011 Jun; 40(6):611-4. PubMed ID: 21570245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.